(0)サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1722930

血漿誘導体の市場規模、シェア、動向、予測：タイプ、用途、エンドユーザー、地域別、2025-2033年

Blood Plasma Derivatives Market Size, Share, Trends and Forecast by Type, Application, End User, and Region, 2025-2033

出版日
発行
IMARC
ページ情報
英文 149 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.70円
血漿誘導体の市場規模、シェア、動向、予測：タイプ、用途、エンドユーザー、地域別、2025-2033年
出版日: 2025年05月01日
発行: IMARC
ページ情報: 英文 149 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の血漿誘導体の市場規模は、2024年に482億7,000万米ドルとなりました。今後、IMARC Groupは、2033年には759億米ドルに達し、2025年から2033年にかけて5.2％のCAGRを示すと予測しています。現在、北米が市場を独占しており、2024年の市場シェアは48.9%を超えています。慢性疾患の増加、先進的な血漿採取インフラ、技術革新、高齢者人口の増加、治療用途の拡大などが、この地域の市場成長を促進する要因となっています。

血漿誘導体のは、分画処理によって得られる血漿から調製された特定のタンパク質の濃縮物です。第VIII因子、免疫グロブリン、アルブミン、高免疫グロブリン、第IX因子、新鮮凍結などは一般的な血漿誘導体の一部です。これらの製剤は、タンパク質、ミネラル、塩類、ホルモン、ビタミン、プロテアーゼ阻害剤を豊富に含んでおり、B型肝炎、血友病A、出血性疾患、免疫不全、C型肝炎、低ガンマグロブリン血症、血友病B、ヒト免疫不全ウイルス（HIV）の原因となるウイルスを殺すために広く使用されています。これ以外にも、血漿誘導体のは栄養強化、体温調節、血液凝固、浸透圧の維持、呼吸と排泄の促進、酸塩基平衡の調節を助けます。血漿誘導体のは一般的に病院、診療所、診断センター、輸血センターで保管されています。

血漿誘導体の市場動向：

感染症に罹患しやすい老年人口の増加が、市場に明るい展望をもたらしています。血漿には免疫の発達に重要な役割を果たす免疫グロブリンが含まれており、血管内の浸透圧を維持することで免疫不全症や血友病の発症を防ぎます。さらに、回復期血漿治療によるコロナウイルス感染症（COVID-19）患者の治療に広く製品が採用されていることも、市場の成長を後押ししています。さらに、臨床目的のために血漿中のタンパク質濃縮物や様々な成分を分離するのに役立つ分画プロセスにおける様々な技術革新が、市場成長にかなりの弾みをつけています。これに伴い、標的治療製品を開発するための封入手順の大幅な改善とともに、高度な保存方法の開発が市場開拓をさらに後押ししています。ヘルスケア産業の著しい成長、献血や血漿提供に関する意識の高まり、献血キャンプを促進するための様々な政府イニシアチブの実施など、その他の要因も市場のさらなる成長を後押しすると予想されます。

本レポートで扱う主な質問

  • 血漿誘導体とは何か？
  • 血漿誘導体の市場の規模は？
  • 2025-2033年における世界の血漿誘導体の市場の予想成長率は？
  • 世界の血漿誘導体の市場を牽引する主要因は？
  • 世界の血漿誘導体の市場におけるタイプ別の主要セグメントは？
  • 世界の血漿誘導体の市場の用途別の主要セグメントは？
  • 世界の血漿誘導体の市場のエンドユーザー別の主要セグメントは？
  • 世界の血漿誘導体の市場における主要地域は？
  • 世界の血漿誘導体の市場における主要プレイヤー/企業は？

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査の目的
  • ステークホルダー
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要業界動向

第5章 世界の血漿誘導体の市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳：タイプ別

  • アルブミン
  • 第VIII因子
  • 第IX因子
  • 免疫グロブリン
  • 高免疫グロブリン
  • その他

第7章 市場内訳：用途別

  • 血友病
  • 低ガンマグロブリン血症
  • 免疫不全疾患
  • フォン・ヴィレブランド病
  • その他

第8章 市場内訳：エンドユーザー別

  • 病院
  • クリニック
  • その他

第9章 市場内訳：地域別

  • 北米
    • 米国
    • カナダ
  • アジア太平洋地域
    • 中国
    • 日本
    • インド
    • 韓国
    • オーストラリア
    • インドネシア
    • その他
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • ロシア
    • その他
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • その他
  • 中東・アフリカ
    • 市場内訳：国別

第10章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第11章 バリューチェーン分析

第12章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第13章 価格分析

第14章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Baxter International Inc.
    • Bayer AG
    • CSL Limited
    • Fusion Health Care Pvt. Ltd.
    • Grifols S.A.
    • Kedrion S.p.A.
    • LFB S.A.
    • Octapharma AG
    • Sanofi S.A.
    • Takeda Pharmaceutical Company Limited
図表

List of Figures

  • Figure 1: Global: Blood Plasma Derivatives Market: Major Drivers and Challenges
  • Figure 2: Global: Blood Plasma Derivatives Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Blood Plasma Derivatives Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: Blood Plasma Derivatives Market: Breakup by Type (in %), 2024
  • Figure 5: Global: Blood Plasma Derivatives Market: Breakup by Application (in %), 2024
  • Figure 6: Global: Blood Plasma Derivatives Market: Breakup by End User (in %), 2024
  • Figure 7: Global: Blood Plasma Derivatives Market: Breakup by Region (in %), 2024
  • Figure 8: Global: Blood Plasma Derivatives (Albumin) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 9: Global: Blood Plasma Derivatives (Albumin) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 10: Global: Blood Plasma Derivatives (Factor VIII) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 11: Global: Blood Plasma Derivatives (Factor VIII) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 12: Global: Blood Plasma Derivatives (Factor IX) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 13: Global: Blood Plasma Derivatives (Factor IX) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 14: Global: Blood Plasma Derivatives (Immunoglobulin) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 15: Global: Blood Plasma Derivatives (Immunoglobulin) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 16: Global: Blood Plasma Derivatives (Hyperimmune Globulin) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 17: Global: Blood Plasma Derivatives (Hyperimmune Globulin) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 18: Global: Blood Plasma Derivatives (Other Types) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 19: Global: Blood Plasma Derivatives (Other Types) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 20: Global: Blood Plasma Derivatives (Hemophilia) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 21: Global: Blood Plasma Derivatives (Hemophilia) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 22: Global: Blood Plasma Derivatives (Hypogammaglobulinemia) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 23: Global: Blood Plasma Derivatives (Hypogammaglobulinemia) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 24: Global: Blood Plasma Derivatives (Immunodeficiency Diseases) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 25: Global: Blood Plasma Derivatives (Immunodeficiency Diseases) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 26: Global: Blood Plasma Derivatives (Von Willebrand's Disease) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 27: Global: Blood Plasma Derivatives (Von Willebrand's Disease) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 28: Global: Blood Plasma Derivatives (Other Applications) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 29: Global: Blood Plasma Derivatives (Other Applications) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 30: Global: Blood Plasma Derivatives (Hospitals) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 31: Global: Blood Plasma Derivatives (Hospitals) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 32: Global: Blood Plasma Derivatives (Clinics) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 33: Global: Blood Plasma Derivatives (Clinics) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 34: Global: Blood Plasma Derivatives (Other End Users) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 35: Global: Blood Plasma Derivatives (Other End Users) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 36: North America: Blood Plasma Derivatives Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 37: North America: Blood Plasma Derivatives Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 38: United States: Blood Plasma Derivatives Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 39: United States: Blood Plasma Derivatives Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 40: Canada: Blood Plasma Derivatives Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 41: Canada: Blood Plasma Derivatives Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 42: Asia-Pacific: Blood Plasma Derivatives Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 43: Asia-Pacific: Blood Plasma Derivatives Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 44: China: Blood Plasma Derivatives Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 45: China: Blood Plasma Derivatives Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 46: Japan: Blood Plasma Derivatives Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 47: Japan: Blood Plasma Derivatives Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 48: India: Blood Plasma Derivatives Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 49: India: Blood Plasma Derivatives Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 50: South Korea: Blood Plasma Derivatives Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 51: South Korea: Blood Plasma Derivatives Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 52: Australia: Blood Plasma Derivatives Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 53: Australia: Blood Plasma Derivatives Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 54: Indonesia: Blood Plasma Derivatives Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 55: Indonesia: Blood Plasma Derivatives Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 56: Others: Blood Plasma Derivatives Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 57: Others: Blood Plasma Derivatives Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 58: Europe: Blood Plasma Derivatives Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 59: Europe: Blood Plasma Derivatives Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 60: Germany: Blood Plasma Derivatives Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 61: Germany: Blood Plasma Derivatives Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 62: France: Blood Plasma Derivatives Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 63: France: Blood Plasma Derivatives Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 64: United Kingdom: Blood Plasma Derivatives Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 65: United Kingdom: Blood Plasma Derivatives Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 66: Italy: Blood Plasma Derivatives Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 67: Italy: Blood Plasma Derivatives Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 68: Spain: Blood Plasma Derivatives Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 69: Spain: Blood Plasma Derivatives Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 70: Russia: Blood Plasma Derivatives Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 71: Russia: Blood Plasma Derivatives Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 72: Others: Blood Plasma Derivatives Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 73: Others: Blood Plasma Derivatives Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 74: Latin America: Blood Plasma Derivatives Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 75: Latin America: Blood Plasma Derivatives Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 76: Brazil: Blood Plasma Derivatives Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 77: Brazil: Blood Plasma Derivatives Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 78: Mexico: Blood Plasma Derivatives Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 79: Mexico: Blood Plasma Derivatives Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 80: Others: Blood Plasma Derivatives Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 81: Others: Blood Plasma Derivatives Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 82: Middle East and Africa: Blood Plasma Derivatives Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 83: Middle East and Africa: Blood Plasma Derivatives Market: Breakup by Country (in %), 2024
  • Figure 84: Middle East and Africa: Blood Plasma Derivatives Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 85: Global: Blood Plasma Derivatives Industry: SWOT Analysis
  • Figure 86: Global: Blood Plasma Derivatives Industry: Value Chain Analysis
  • Figure 87: Global: Blood Plasma Derivatives Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Blood Plasma Derivatives Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Blood Plasma Derivatives Market Forecast: Breakup by Type (in Million USD), 2025-2033
  • Table 3: Global: Blood Plasma Derivatives Market Forecast: Breakup by Application (in Million USD), 2025-2033
  • Table 4: Global: Blood Plasma Derivatives Market Forecast: Breakup by End User (in Million USD), 2025-2033
  • Table 5: Global: Blood Plasma Derivatives Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 6: Global: Blood Plasma Derivatives Market: Competitive Structure
  • Table 7: Global: Blood Plasma Derivatives Market: Key Players
目次
Product Code: SR112025A5371

The global blood plasma derivatives market size was valued at USD 48.27 Billion in 2024. Looking forward, IMARC Group estimates the market to reach USD 75.9 Billion by 2033, exhibiting a CAGR of 5.2% from 2025-2033. North America currently dominates the market, holding a market share of over 48.9% in 2024. The rising chronic disease prevalence, advanced plasma collection infrastructure, technological innovations, growing geriatric population, and expanding therapeutic applications are some of the factors driving the market growth in this region.

Blood plasma derivatives are concentrates of specific proteins prepared from plasma that are obtained through fractionation process. Factor VIII, immunoglobulin, albumin, hyperimmune globulin, factor IX and fresh frozen are some of the common blood plasma derivatives. They are rich in proteins, minerals, salts, hormones, vitamins and protease inhibitors, due to which they are widely used to kill viruses that cause hepatitis B, hemophilia A, bleeding disorders, immunodeficiency, hepatitis C, hypogammaglobulinemia, hemophilia B and human immunodeficiency virus (HIV). Apart from this, blood plasma derivatives assist in enhancing nutrition, controlling body temperature and coagulation of blood, maintaining osmotic pressure, enhancing respiration and excretion, and regulating acid-base balance. Blood plasma derivatives are commonly stored at hospitals, clinics, diagnostic centers and blood transfusion centers.

Blood Plasma Derivatives Market Trends:

The increasing geriatric population that are more susceptible to developing infectious diseases are creating a positive outlook for the market. Blood plasma contains immunoglobulins that play an important role in the development of immunity and maintain the osmotic pressure in blood vessels, which further prevents the onset immunodeficiency disorders and hemophilia. Moreover, the widespread product adoption to treat coronavirus disease (COVID-19) patients by convalescent plasma treatment is favoring the market growth. Additionally, various technological innovations in the fractionation process that aids in separating protein concentrates and various components of blood plasma for clinical purposes are providing a considerable boost to the market growth. In line with this, the development of advanced preservation methods, along with the significant improvements in encased procedures for developing targeted therapeutic products are further augmenting the market growth. Other factors, including significant growth in the healthcare industry, increasing awareness regarding blood and plasma donation and the implementation of various government initiatives to promote blood donation camps, are anticipated to drive the market further toward growth.

Key Market Segmentation:

Breakup by Type:

  • Albumin
  • Factor VIII
  • Factor IX
  • Immunoglobulin
  • Hyperimmune Globulin
  • Others

Breakup by Application:

  • Hemophilia
  • Hypogammaglobulinemia
  • Immunodeficiency Diseases
  • Von Willebrand's Disease
  • Others

Breakup by End User:

  • Hospitals
  • Clinics
  • Others

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Baxter International Inc., Bayer AG, CSL Limited, Fusion Health Care Pvt. Ltd., Grifols S.A., Kedrion S.p.A., LFB S.A., Octapharma AG, Sanofi S.A. and Takeda Pharmaceutical Company Limited.

Key Questions Answered in This Report

  • 1.What are blood plasma derivatives?
  • 2.How big is the blood plasma derivatives market?
  • 3.What is the expected growth rate of the global blood plasma derivatives market during 2025-2033?
  • 4.What are the key factors driving the global blood plasma derivatives market?
  • 5.What is the leading segment of the global blood plasma derivatives market based on type?
  • 6.What is the leading segment of the global blood plasma derivatives market based on application?
  • 7.What is the leading segment of the global blood plasma derivatives market based on end user?
  • 8.What are the key regions in the global blood plasma derivatives market?
  • 9.Who are the key players/companies in the global blood plasma derivatives market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Blood Plasma Derivatives Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 Albumin
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Factor VIII
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Factor IX
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Immunoglobulin
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Hyperimmune Globulin
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast
  • 6.6 Others
    • 6.6.1 Market Trends
    • 6.6.2 Market Forecast

7 Market Breakup by Application

  • 7.1 Hemophilia
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Hypogammaglobulinemia
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Immunodeficiency Diseases
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Von Willebrand's Disease
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Others
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Hospitals
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Clinics
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Others
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Baxter International Inc.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Bayer AG
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 CSL Limited
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Fusion Health Care Pvt. Ltd.
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
    • 14.3.5 Grifols S.A.
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 Kedrion S.p.A.
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
    • 14.3.7 LFB S.A.
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
    • 14.3.8 Octapharma AG
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 SWOT Analysis
    • 14.3.9 Sanofi S.A.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10 Takeda Pharmaceutical Company Limited
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis